Abstract:Objective To investigate the expressions of CD133 and CD44 protein in primary lesions of gastric cancer and its clinical significance. Methods The expressions of CD44 and CD133 protein in gastric cancer tissues of100 patients with gastric cancer were detected by immunohistocheimcal stainings. The relation between the expressions of CD44 and CD133 protein and the clinicopathologic characters were analyzed. Results Both CD44 and CD133protein were expressed on the cell membranes. No correlation were found between CD44/CD133 and the clinicopathologic parameters include gender and age(P0.05), but the positive expression rate of CD44/CD133 with diameter5 cm was significantly higher than that tumor with diameter ≤5 cm(CD44 P=0.150;CD133 P=0.056), and correlated with the tissue differentiation(CD44 P=0.008;CD133 P=0.007), vascular invasion(CD44 P=0.043;CD133 P=0.023), lymphatic vessel invasion(CD44 P=0.020;CD133 P=0.044), lymph nodes metastasis(CD44 P=0.002;CD133 P=0.004), invasion depth of tumor(CD44 P=0.006;CD133 P=0.021), and pTNM stage(CD44 P=0.034;CD133 P=0.001). No correlation were found between the co-expression of CD44 and CD133 protein and the clinicopathologic parameters include gender, age, tissue differentiation, and vascular invasion(P0.05), but the positive co-expression rate of CD44 and CD133 with diameter 5 cm was significantly higher than that tumor with diameter ≤5 cm(P=0.010), and correlated with lymphatic vessel invasion(P=0.003), lymph nodes metastasis(P=0.045), invasion depth of tumor(P=0.041), and pTNM stage(P=0.049). The Spearman rank correlation analysis showed that there was positive correlation between the expressions of CD44 and CD133 protein(r =0.207, P=0.039). Univariate analysis showed that lymph nodes metastasis(P0.001), pTNM stages(P=0.013), CD44 protein expression(P=0.005), CD133 protein expression(P=0.002), and co-expression of CD44 and CD133 protein(P0.001) were significantly correlated with 3-year survival rate of patients with gastric cancer respectively. Logistic regression analysis revealed that lymph node metastasis(P=0.038) was independent risk factor for co-expression of CD44 and CD133 protein. Multivariate analysis with the Cox regression models showed that co-expression of CD44 and CD133 protein(P=0.003) and lymph node metastasis(P=0.006) were significantly associated with poor prognosis. Conclusions CD44 and CD133 protein may be considered as robust cancer stem cell markers in gastric cancer. The co-expression of CD44 and CD133 protein is the independent prognosis factor for gastric cancer and strongly associated with poor prognosis when they are expressed more high.

Expressions of P-gp and CD44v6 in Gastric Carcinoma and Their Correlation to Clinical Prognosis.

[Expression and Clinical Significance of CD44v6 and Scd44v6 in Gastric Carcinoma].

Clinicopathological and related gene analysis in gastric adenocarcinoma and their correlation with prognosis

High GP73 Expression Correlates with Poor Response to Neoadjuvant Chemotherapy and Survival in Gastric Cancer: A Tissue Microarray Study.

The Clinical Significance of the CD44v6 Expression in Peripheral Blood Mononuclear Cell and Cancerous Tissue of Patients with Gastric Cancer

Expression of CD44v6 and the Relationship of Prognosis in Human Gastric Carcinoma

Expression and Prognostic Significance of CD44v6 in Primary Gastric Carcinoma

Expression of HER-2/neu,PTEN and CD44V6 in Gastric Cancer Tissue and Its Correlation with the Prognosis of Gastric Cancer

Expression of P-glycoprotein, topoisomerase II and glutathione S-transferase π in gastric carcinoma and their correlations with clinical prognosis

Role of CD97stalkand CD55 As Molecular Markers for Prognosis and Therapy of Gastric Carcinoma Patients

Evaluation of the Prognostic Value and Functional Roles of CD44v6 in Gastric Cancer

Expression of P53, EGFR, HER-2, VEGF in Gastric Carcinoma and Its Relation with the Prognosis of Gastric Carcinoma Patients

Relationship Between Lymph Node Metastasis and Expression of P53,pkc and CD44V6 in Human Gastric Cancer

CD44 and CD44v6 Are Correlated with Gastric Cancer Progression and Poor Patient Prognosis: Evidence from 42 Studies

Expressions of CD133 and CD44 Protein in Primary Lesion of Gastric Cancer and Its Clinical Significance

The Clinical Significance of Tumor Angiogenesis and Invasiveness-Related Gene Expressions in Gastric Cancer

The expression of CD44V6,p53 and PCNA in gastric cancer

Expressions of CD133 and GW112 in Gastric Cancer and Their Correlations with Prognosis

Expression of Ezrin and CD44v6 and Their Clinical Significance in Gastric Carcinoma

Clinical Analysis of Expression of Multidrug Resistance-associated Protein in Gastric Carcinoma

Detection of Lgr5 and CD44 expression in gastric cancer using tissue microarrays